September 9, 2010
Dr. Kevin Ong, Dr. Marta Villarraga, Mr. Edmund Lau, and Dr. Steve Kurtz recently published an article in Spine on the off-label use of growth factors known as bone morphogenetic proteins (BMP). In this article, the Exponent team and other co-authors analyzed the types of procedures involving the use of BMP from a nationwide sample of hospital discharges in the U.S. They found that the annual number of procedures involving BMP increased by 4.3-fold between 2003 and 2007. At least 85% of principal procedures using BMP were found to be for off-label applications. Click here to read the abstract.
|

PrincipalSenior Manager
|